{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:55:06Z","timestamp":1791219306233,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011851","name":"Fight against Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007229","name":"Bijzonder Onderzoeksfonds UGent","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004385","name":"Ghent University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods & Clinical Development"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.omtm.2025.101493","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T19:56:46Z","timestamp":1747684606000},"page":"101493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Preclinical toxicological assessment of an \u03b1-galactosylceramide-adjuvanted mRNA cancer vaccine in Wistar Han rats and domestic pigs"],"prefix":"10.1016","volume":"33","author":[{"given":"Sofie","family":"Meulewaeter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margo","family":"De Velder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diethard","family":"Reckelbus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Mwangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ehouarne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilke","family":"Aernout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanou","family":"Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fellanza","family":"Halimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isis","family":"Van herteryck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lobke","family":"De Bels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Redant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"De la Mane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joline","family":"Ingels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Coppens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Van Calenbergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Cornillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabri\u00eble","family":"Holtappels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Vanrompay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefaan C.","family":"De Smedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Van den Broeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Vandekerckhove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Devreese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1849-5411","authenticated-orcid":false,"given":"Rein","family":"Verbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ine","family":"Lentacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101493_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.omtm.2025.101493_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-023-01740-y","article-title":"Lung cancer immunotherapy: progress, pitfalls, and promises","volume":"22","author":"Lahiri","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omtm.2025.101493_bib3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1200\/JCO.22.00096","article-title":"Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients with Refractory Advanced Non-Small-Cell Lung Cancer: A Phase Ib\/Phase IIa De-Escalation Study","volume":"41","author":"Adot\u00e9vi","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.omtm.2025.101493_bib4","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.annonc.2023.07.006","article-title":"Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1","volume":"34","author":"Besse","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.omtm.2025.101493_bib5","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1158\/1078-0432.CCR-15-0855","article-title":"A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients","volume":"22","author":"Rodriguez","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omtm.2025.101493_bib6","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(23)02268-7","article-title":"Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study","volume":"403","author":"Weber","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2025.101493_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","article-title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer","volume":"618","author":"Rojas","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101493_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41586-020-2537-9","article-title":"An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma","volume":"585","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101493_bib9","first-page":"1655","article-title":"Broadening the Message: A Nanovaccine Co-loaded with Messenger RNA and \u03b1-GalCer Induces Antitumor Immunity through Conventional and Natural Killer T Cells","volume":"13","author":"Verbeke","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.omtm.2025.101493_bib10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/jitc-2019-000316","article-title":"Phase II study of \u03b1-galactosylceramide-pulsed antigen-presenting cells in patients with advanced or recurrent non-small cell lung cancer","volume":"8","author":"Toyoda","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.omtm.2025.101493_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jcyt.2021.08.005","article-title":"Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials","volume":"24","author":"Ingels","year":"2022","journal-title":"Cytotherapy"},{"key":"10.1016\/j.omtm.2025.101493_bib14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/eji.201242565","article-title":"Direct identification of rat iNKT cells reveals remarkable similarities to human iNKT cells and a profound deficiency in LEW rats","volume":"43","author":"Monzon-Casanova","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omtm.2025.101493_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01380","article-title":"Porcine invariant natural killer T cells: Functional profiling and dynamics in steady state and viral infections","volume":"10","author":"Sch\u00e4fer","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2025.101493_bib16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s10875-010-9476-4","article-title":"Functional Invariant NKT Cells in Pig Lungs Regulate the Airway Hyperreactivity: A Potential Animal Model","volume":"31","author":"Renukaradhya","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.omtm.2025.101493_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetimm.2014.09.006","article-title":"Adjuvant effects of therapeutic glycolipids administered to a cohort of NKT cell-diverse pigs","volume":"162","author":"Artiaga","year":"2014","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.omtm.2025.101493_bib18","article-title":"Toxicological Assessments of a Pandemic COVID-19 Vaccine\u2014Demonstrating the Suitability of a Platform Approach for mRNA Vaccines","volume":"11","author":"Rohde","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.omtm.2025.101493_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.vetimm.2006.04.008","article-title":"The porcine acute phase protein response to acute clinical and subclinical experimental infection with Streptococcus suis","volume":"113","author":"Sorensen","year":"2006","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.omtm.2025.101493_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1297-9716-42-50","article-title":"Optimal combinations of acute phase proteins for detecting infectious disease in pigs","volume":"42","author":"Heegaard","year":"2011","journal-title":"Vet Res"},{"key":"10.1016\/j.omtm.2025.101493_bib22","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1016\/j.vaccine.2012.02.044","article-title":"Protection of pigs against genital Chlamydia trachomatis challenge by parenteral or mucosal DNA immunization","volume":"30","author":"Schautteet","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.omtm.2025.101493_bib23","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.4049\/jimmunol.1801171","article-title":"Next Generation Sequencing of the Pig \u03b1\u03b2 TCR Repertoire Identifies the Porcine Invariant NKT Cell Receptor","volume":"202","author":"Yang","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtm.2025.101493_bib24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.vetimm.2012.06.023","article-title":"Identification of invariant natural killer T cells in porcine peripheral blood","volume":"149","author":"Thierry","year":"2012","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.omtm.2025.101493_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.yrtph.2013.04.003","article-title":"A global pharmaceutical company initiative: An evidence-based approach to define the upper limit of body weight loss in short term toxicity studies","volume":"67","author":"Chapman","year":"2013","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.omtm.2025.101493_bib26","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2741\/1341","article-title":"Cytokines and fever","volume":"9","author":"Conti","year":"2004","journal-title":"Front. Biosci."},{"key":"10.1016\/j.omtm.2025.101493_bib27","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41590-022-01160-y","article-title":"IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines","volume":"23","author":"Tahtinen","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omtm.2025.101493_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.omtm.2025.101493_bib29","author":"Alameh"},{"key":"10.1016\/j.omtm.2025.101493_bib30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4103\/0975-7406.76489","article-title":"Acute-phase proteins: As diagnostic tool","volume":"3","author":"Jain","year":"2011","journal-title":"J. Pharm. BioAllied Sci."},{"key":"10.1016\/j.omtm.2025.101493_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00087","article-title":"Divergent roles of inflammation in skeletal muscle recovery from injury","volume":"11","author":"Howard","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.omtm.2025.101493_bib32","article-title":"Unsaturated, trialkyl Ionizable lipids are versatile lipid-nanoparticle components for therapeutic and vaccine applications","volume":"35","author":"Lam","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omtm.2025.101493_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","article-title":"Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines","volume":"15","author":"Hassett","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtm.2025.101493_bib34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jconrel.2024.04.052","article-title":"Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria","volume":"370","author":"Meulewaeter","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.omtm.2025.101493_bib35","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.omtm.2025.101493_bib36","author":"CHMP"},{"key":"10.1016\/j.omtm.2025.101493_bib37","author":"CHMP"},{"key":"10.1016\/j.omtm.2025.101493_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031786","article-title":"Interplay between inflammation and pathological bone resorption: insights into recent mechanisms and pathways in related diseases for future perspectives","volume":"23","author":"Terkawi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2025.101493_bib39","first-page":"3667","article-title":"Liver Injury After Invariant NKT Cell Activation by Free Alpha-galactosylceramide and Alpha-galactosylceramide-loaded Dendritic Cells","volume":"36","author":"Hasegawa","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.omtm.2025.101493_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24852","article-title":"Pyroptosis in platelets: Thrombocytopenia and inflammation","volume":"37","author":"Su","year":"2023","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.omtm.2025.101493_bib41","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood-2013-11-536003","article-title":"Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis","volume":"124","author":"Koupenova","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101493_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi0508","article-title":"Genetically engineered transfusable platelets using mRNA lipid nanoparticles","volume":"9","author":"Leung","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtm.2025.101493_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-36910-2","article-title":"Delivery of mRNA to platelets using lipid nanoparticles","volume":"9","author":"Novakowski","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2025.101493_bib44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/14782715221103660","article-title":"A probable case of vaccine-induced immune thrombotic thrombocytopenia secondary to Pfizer Comirnaty COVID-19 vaccine","volume":"52","author":"Goh","year":"2022","journal-title":"J. R. Coll. Physicians Edinb."},{"key":"10.1016\/j.omtm.2025.101493_bib45","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1182\/blood.2022017696","article-title":"Vaccine-induced immune thrombotic thrombocytopenia","volume":"141","author":"Cines","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101493_bib46","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/s41418-018-0245-x","article-title":"Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem\/progenitor cells","volume":"26","author":"Orsini","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.omtm.2025.101493_bib47","first-page":"853","article-title":"The inhibitory effect of the proinflammatory cytokine TNFalpha on erythroid differentiation involves erythroid transcription factor modulation","volume":"34","author":"Buck","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.omtm.2025.101493_bib48","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood-2010-10-315218","article-title":"Chronic IFN-\u03b3 production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1\/PU.1 axis","volume":"118","author":"Libregts","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101493_bib49","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood-2013-08-521625","article-title":"Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus","volume":"123","author":"Gardenghi","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101493_bib50","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1073\/pnas.1833166100","article-title":"The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion","volume":"100","author":"Wilson","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101493_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-45526-2","article-title":"Immune signature of Chlamydia vaccine CTH522\/CAF\u00ae01 translates from mouse-to-human and induces durable protection in mice","volume":"15","author":"Olsen","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2025.101493_bib52","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1021\/jo0201530","article-title":"Synthesis of \u03b1-galactosyl ceramide, a potent immunostimulatory agent","volume":"67","author":"Plettenburg","year":"2002","journal-title":"J. Org. Chem."}],"container-title":["Molecular Therapy Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125000889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125000889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T18:54:09Z","timestamp":1759863249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125000889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2329050125000889"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101493","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical toxicological assessment of an \u03b1-galactosylceramide-adjuvanted mRNA cancer vaccine in Wistar Han rats and domestic pigs","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101493"}}